Gentian Diagnostics AS is pleased to announce that the results from a study conducted in collaboration with University College of London (UCL) are published in Critical Care 2020, Meeting Abstracts from the 40th International Symposium on Intensive Care & Emergency Medicine. The results indicate that calprotectin can be used as an early biomarker for infection and inflammation. The study also shows earlier release of calprotectin compared to other conventional biomarkers (procalcitonin and C-reactive protein (CRP)). Early activation of immune response and recognition of bacterial infection and sepsis is a key step for early and correct initiation of antibiotic treatment. Calprotectin is released by neutrophils upon their activation and may thus act as an early biomarker of inflammation and bacterial infection.
Hilja Ibert CEO, Gentian Diagnostics
Cell Phone: +47 919 05 242
Cell Phone. +47 919 06 525